Skip to content

JCVI statement on use of the AstraZeneca COVID-19 vaccine (7 April 2021)

by Patient Safety Learning

· 1,477 views

Summary

The Medicines and Healthcare products Regulatory Agency (MHRA) and the Joint Committee on Vaccinations and Immunisation (JCVI) has issued new advice suggesting people under the age of 30 with no underlying health conditions should receive an alternative to the AstraZeneca vaccine, where available. 

Both the MHRA and JCVI have stressed that vaccination is highly effective and substantially reduces the risk of infection and severe COVID-19 disease.

JCVI statement on use of the AstraZeneca COVID-19 vaccine (7 April 2021) https://www.gov.uk/government/publications/use-of-the-astrazeneca-covid-19-vaccine-jcvi-statement/jc…
    • 0

    User Feedback

    Recommended Comments

    There are no comments to display.

    Create an account or sign in to comment

    Registered address: Patient Safety Learning, China Works SB203, 100 Black Prince Road Vauxhall, London, SE1 7SJ

    Account

    Navigation

    Search

    Search

    Configure browser push notifications
    Chrome (Android)
    1. Tap the lock icon next to the address bar.
    2. Tap Permissions → Notifications.
    3. Adjust your preference.
    Chrome (Desktop)
    1. Click the padlock icon in the address bar.
    2. Select Site settings.
    3. Find Notifications and adjust your preference.